Altasciences - About the company
Altasciences is an acquired company based in Laval (Canada), founded in 2015 by Johanna NA and Christopher Perkin. It operates as an Early phase CRO. The company has 100 active competitors, including 7 funded and 23 that have exited. Its top competitors include companies like Celerion, BioPharma Services and MindBio Therapeutics.
Company Details
Altasciences Clinical Research is an early phase clinical research organisations (CRO) offering its services in North America. Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, Canada, Vince & Associates Clinical Research in Overland Park, USA, as well as Algorithme Pharma USA in Fargo, ND. It conducts clinical trials in Phase I/IIa, bioequivalence, and bioanalysis (preclinical to Phase I-IV).
- Website
- www.altasciences.com/
- Email ID
- *****@altasciences.com
- Registered Address
- Fargo,North Dakota
Key Metrics
Founded Year
2015
Location
Laval, Canada
Stage
Acquired
Investors
Ranked
2nd among 100 active competitors
Employee Count
1 as on Aug 31, 2026
Investment & Acquisitions
Exit Details
Acquired by Novo Holdings (Feb 22, 2021)
Legal entities associated with Altasciences
Altasciences is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
ALGORITHME PHARMA USA, LLC CIN: 383940620 , United States, Active | - | 1 (As on Dec 31, 2018) | - | |
ALTASCIENCES PRECLINICAL SEATTLE, LLC CIN: 831352782 , United States, Active | - | 249 (As on Dec 31, 2020) | - |
Altasciences's acquisition details
Altasciences got acquired by Novo Holdings on Feb 22, 2021.
Click here to take a look at Altasciences's acquisition in detail
Sign up to download Altasciences' company profile
Altasciences's funding and investors
Altasciences is a funded company. Altasciences has 3 institutional investors.
View details of Altasciences's funding rounds and investors
Altasciences' founders and board of directors
Founder? Claim ProfileThe founders of Altasciences are Johanna NA and Christopher Perkin.
Here are the details of Altasciences' key team members:
- Johanna NA: Co-Founder of Altasciences.
- Christopher Perkin: CEO/Founder 2004-16; Chief Medical Officer 2016-18 of Altasciences.
View details of Altasciences's Founder profiles and Board Members
Altasciences' employee count trend
Altasciences has 1 employees as of Aug 26. Here is Altasciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Altasciences's Competitors and alternates
Top competitors of Altasciences include Celerion, BioPharma Services and MindBio Therapeutics. Here is the list of Top 10 competitors of Altasciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Celerion 2010, Lincoln (United States), Acquired | Translational medicine experts accelerating drug development for global patient impact | - | 51/100 | |
2nd | Altasciences 2015, Laval (Canada), Acquired | Early phase CRO | - | 50/100 | |
3rd | BioPharma Services 2006, Toronto (Canada), Acquired | Provider of early stage clinical trial services | - | - | 48/100 |
4th | MindBio Therapeutics 2021, Melbourne (Australia), Public | Provider of phase I & II clinical trial services for mental health diseases | - | 44/100 | |
5th | Avance Clinical 2018, Thebarton (Australia), Late Stage | Provider of clinical development services | - | 43/100 | |
6th | Aditum Bio 2019, Cambridge (United States), Unfunded | CRO focused on clinical trial on phase II studies | - | - | 42/100 |
7th | iCardiac Technologies 2006, Rochester (United States), Acquired | Company offering core laboratory services mainly for cardiac safety testing and respiratory diseases | $4M | 41/100 | |
8th | Unravel Biosciences 2020, Boston (United States), Seed | CRO offering early stage clinical development of drugs | $500K | 41/100 | |
9th | Ventura Biomed 2021, Germany, Unfunded | CRO offering early stage drug development services | - | - | 40/100 |
10th | Biomind Labs 2005, Toronto (Canada), Public | Developer of novel pharmaceuticals targeting neurological disorders and related conditions | - | - | 39/100 |
Looking for more details on Altasciences's competitors? Click here to see the top ones
Altasciences's Investments and acquisitions
Altasciences has not made any investments yet. Altasciences has made 7 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jan 04, 2022 | Acquisition | 1964 | Columbia (United States) | |
May 05, 2021 | Acquisition | 1969 | Pennsylvania Furnace (United States) | |
Feb 19, 2021 | Acquisition | 1998 | Cypress (United States) |
See all acquisitions by Altasciences
Reports related to Altasciences
Here is the latest report on Altasciences's sector:
News related to Altasciences
Media has covered Altasciences for a total of 15 events in the last 1 year, 5 of them have been about company updates and 4 about people movement.
•
Altasciences is supporting 4B Healthcare in its transition from steroid nasal irrigation to clinical trialsBusiness Wire•Sep 25, 2026•Altasciences
•
Altasciences verstärkt seine Kapazitäten für Bioanalytik in NordamerikaBusiness Wire•Aug 11, 2026•Altasciences
•
•
Altasciences and Evidence Matters Advance AI-Driven Drug Development With Nonclinical Automation BreakthroughFinancial Post•Jul 07, 2026•Evidence Matters, Altasciences
•
Ona Therapeutics Secures 74 Million Euros to Advance Oncology Drug DevelopmentExpansion•Jun 04, 2026•Ona Therapeutics, Columbus Venture Partners, Merieux Equity Partners, Cuatrecasas and 6 others
•
Altasciences and Certara announce a strategic partnership to accelerate early drug developmentBusiness Wire•May 08, 2026•Altasciences, Certara
•
Peptomyc Obtains Five Million Euros in Funding RoundEl Referente•Apr 09, 2026•Peptomyc, Altasciences
•
Altasciences announces the appointment of Chris Perkin as member of the Board of Directors and Marie-Hélène Raigneau as CEOBusiness Wire•Mar 02, 2026•Altasciences
•
Altasciences Announces Chris Perkin Appointed Executive Chairman; Marie-Hélène Raigneau Appointed Chief Executive OfficerFinancial Post•Feb 12, 2026•Altasciences
•
Are you a Founder ?
FAQs about Altasciences
Explore our recently published companies
- John M Orr - Unfunded company
- Spark Associates - India based, Unfunded company
- Matek Oozis - Hungary based, Unfunded company
- MINOTERIE GIRARDEAU - Boussay based, 1895 founded, Unfunded company
- Mfiber - Springfield based, 2015 founded, Unfunded company
- Landon - Finland based, Unfunded company